دورية أكاديمية

Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials.

التفاصيل البيبلوغرافية
العنوان: Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials.
المؤلفون: Yao, James, Garg, Abhishek, Chen, David, Capdevila, Jaume, Engstrom, Paul, Pommier, Rodney, Van Cutsem, Eric, Singh, Simron, Fazio, Nicola, Wei He, Riester, Markus, Patel, Parul, Voi, Maurizio, Morrissey, Michael, Pavel, Marianne, Kulke, Matthew Helmut
المصدر: Endocrine-Related Cancer; Apr2019, Vol. 26 Issue 4, p391-403, 13p
مصطلحات موضوعية: NEUROENDOCRINE tumors, TUMOR grading, CLINICAL trials, ENOLASE, MULTIVARIATE analysis
مستخلص: Neuroendocrine tumors (NETs) have historically been subcategorized according to histologic features and the site of anatomic origin. Here, we characterize the genomic alterations in patients enrolled in three phase 3 clinical trials of NET of different anatomic origins and assess the potential correlation with clinical outcomes. Whole-exome and targeted panel sequencing was used to characterize 225 NET samples collected in the RADIANT series of clinical trials. Genomic profiling of NET was analyzed along with nongenomic biomarker data on the tumor grade and circulating chromogranin A (CgA) and neuron-specific enolase (NSE) levels from these patients enrolled in clinical trials. Our results highlight recurrent large-scale chromosomal alterations as a common theme among NET. Although the specific pattern of chromosomal alterations differed between tumor subtypes, the evidence for generalized chromosomal instability (CIN) was observed across all primary sites of NET. In pancreatic NET, although the P value was not significant, higher CIN suggests a trend toward longer survival (HR, 0.55, P = 0.077), whereas in the gastrointestinal NET, lower CIN was associated with longer survival (HR, 0.44, P = 0.0006). Our multivariate analyses demonstrated that when combined with other clinical data among patients with progressive advanced NETs, chromosomal level alteration adds important prognostic information. Large-scale CIN is a common feature of NET, and specific patterns of chromosomal gain and loss appeared to have independent prognostic value in NET subtypes. However, whether CIN in general has clin ical significance in NET requires validation in larger patient cohort and warrants further mechanistic studies. [ABSTRACT FROM AUTHOR]
Copyright of Endocrine-Related Cancer is the property of Bioscientifica and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:13510088
DOI:10.1530/ERC-18-0332